The analysis was published as a preprint on medRxiv, meaning it has not yet been peer reviewed
Monitoring Parameters and Safety Measures Clinical safety should be at the forefront of every NAD+ injection protocol
Scirica BM, Bhatt DL, Braunwald E, Steg PG, Davidson J, Hirshberg B, Ohman P, Frederich R, Wiviott SD, Hoffman EB, et al
With nearly a third of employees willing to change jobs over this benefit, GLP-1 coverage is no longer a clinical decision delegated to the benefits team
Direct comparisons help contextualize why provider selection depends on individual metabolic factors, not brand alone
Frierson HF Jr, Mills SE, Fechner RE, Taxy JB, Levine PA